The Fred Hutchinson Cancer Research Center (FHCRC) is a comprehensive, multi-disciplinary research center which uses basic and applied research to eliminate cancer as a cause of human suffering. Advances at the FHCRC in the areas of cancer prevention, diagnosis, and treatment are coupled with the progress made toward understanding the mechanisms of neoplastic development as well as basic aspects of cellular and molecular biology common to all organisms. The FHCRC employs over 2,300 faculty and staff and is organized into twenty collaborative programs: Biostatistics, Breast Cancer Research, Cancer Biology, Cancer Prevention Research, Cell Cycle and Growth Control, Clinical Transplant Research, Complications of Cancer Treatment, Developmental Biology, Epidemiology, Gastrointestinal Oncology, the developing program in Genetics, Human Immunogenetics, Immunology, Infectious Diseases, Molecular and Cellular Biology, Molecular Medicine, Molecular Pharmacology, Pediatric Oncology, the developing program in Prostate Cancer Research and Transplantation Biology. The high quality of research conducted in the scientific programs of the FHCRC is reflected in the level of funding from peer-reviewed, research grants and contracts. This application proposes continued support for Cancer Center Support Grant activities including senior leaders, program leaders, staff investigators, planning and evaluation, developmental funding, administration, protocol data review and monitoring, phase I/II trials and 20 shared resources.
The aims of the CCSG is to (1) provide support for the research infrastructure of the FHCRC and (2) promote and stimulate interdisciplinary research through enhanced collaborations among the scientific programs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA015704-26
Application #
2856185
Study Section
Subcommittee G - Education (NCI)
Program Officer
Marino, Michael A
Project Start
1977-01-01
Project End
2002-12-31
Budget Start
1999-01-01
Budget End
1999-12-31
Support Year
26
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Gauthier, Jordan; Turtle, Cameron J (2018) Insights into cytokine release syndrome and neurotoxicity after CD19-specific CAR-T cell therapy. Curr Res Transl Med 66:50-52
Graves, Scott S; Parker, Maura H; Stone, Diane et al. (2018) Anti-Inducible Costimulator Monoclonal Antibody Treatment of Canine Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant 24:50-54
Méndez, Eduardo; Rodriguez, Cristina P; Kao, Michael C et al. (2018) A Phase I Clinical Trial of AZD1775 in Combination with Neoadjuvant Weekly Docetaxel and Cisplatin before Definitive Therapy in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res 24:2740-2748
Amundsen, Susan K; Smith, Gerald R (2018) The RecB helicase-nuclease tether mediates Chi hotspot control of RecBCD enzyme. Nucleic Acids Res :
Montgomery, Elizabeth T; Noguchi, Lisa M; Dai, James Y et al. (2018) Acceptability of and Adherence to an Antiretroviral-Based Vaginal Microbicide among Pregnant Women in the United States. AIDS Behav 22:402-411
Buckley, Sarah A; Percival, Mary-Elizabeth; Othus, Megan et al. (2018) A comparison of patients with acute myeloid leukemia and high-risk myelodysplastic syndrome treated on versus off study. Leuk Lymphoma :1-7
Rañola, John Michael O; Liu, Quanhui; Rosenthal, Elisabeth A et al. (2018) A comparison of cosegregation analysis methods for the clinical setting. Fam Cancer 17:295-302
Talarico, Sarah; Leverich, Christina K; Wei, Bing et al. (2018) Increased H. pylori stool shedding and EPIYA-D cagA alleles are associated with gastric cancer in an East Asian hospital. PLoS One 13:e0202925
Zhao, Shanshan; Leonardson, Amy; Geybels, Milan S et al. (2018) A five-CpG DNA methylation score to predict metastatic-lethal outcomes in men treated with radical prostatectomy for localized prostate cancer. Prostate :
Greenbaum, Adam M; Green, Damian J; Holmberg, Leona A et al. (2018) Bendamustine, etoposide, and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in non-Hodgkin lymphoma. Blood Res 53:223-226

Showing the most recent 10 out of 1267 publications